Role of chemotherapy in breast cancer (Q36334921)

13 August 2017

1 reference

title

Role of chemotherapy in breast cancer (English)

1 reference

13 August 2017

1 reference

Syed A Hussain

1 reference

13 August 2017

Daniel H Palmer

1 reference

13 August 2017

Andrea Stevens

1 reference

13 August 2017

David Spooner

1 reference

13 August 2017

Christopher J Poole

1 reference

13 August 2017

Daniel W Rea

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Expert Review of Anticancer Therapy

13 August 2017

published in

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

1095-1110

1 reference

The curability of breast cancer and the treatment of advanced disease.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Endocrine therapy and other targeted therapies for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Development of pharmacogenomic markers to select preoperative chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Randomized trial comparing six versus three cycles of epirubicin-based adjuvant chemotherapy in premenopausal, node-positive breast cancer patients: 10-year follow-up results of the French Adjuvant Study Group 01 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Docetaxel and paclitaxel in the treatment of breast cancer: a review of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Adjuvant docetaxel for node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Breast-conserving therapy with adjuvant paclitaxel and radiation therapy: feasibility of concurrent treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Effect of Addition of Adjuvant Paclitaxel on Radiotherapy Delivery and Locoregional Control of Node-Positive Breast Cancer: Cancer and Leukemia Group B 9344

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

Simultaneous adjuvant radiotherapy and chemotherapy for stage I and II breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.5.6.1095

10.1586/14737140.5.6.1095

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference